Erschienen in:
01.05.2008 | Poster presentation
Brk expression may affect the differentiation status of breast cancer cells
verfasst von:
AJ Harvey, CJ Pennington, DR Edwards, SA Eccles, MR Crompton
Erschienen in:
Breast Cancer Research
|
Sonderheft 2/2008
Einloggen, um Zugang zu erhalten
Excerpt
The breast tumour kinase Brk (PTK6) is found in over two-thirds of breast cancer cell lines and tumours but is not expressed in normal mammary cells. Brk has previously been shown to play a role in regulating proliferation in breast tumour cells [
1]. However,
in vivo, the site of Brk expression in normal tissues is restricted to nonproliferating cells that are undergoing terminal differentiation such as those in the gut or the skin [
2,
3]. This led us to hypothesise that Brk expression in breast tumours could be reflective of a differentiation phenotype, especially as a previous study had shown that involucrin, a marker of terminal keratinocyte differentiation, was expressed in a subset of tumours [
4]. We therefore examined involucrin expression in breast tumour cells lines and patient biopsy samples. In addition we investigated whether inducers of differentiation in keratinocytes such as prolonged culture in suspension or vitamin D3 treatment could also affect differentiation of breast tumour cells. …